D.R. Chandam et al. / Journal of Molecular Liquids 219 (2016) 573–578
575
Scheme 2. Preparation of oxalic acid dihydrate: proline LTTM.
2. 5′-Bromo-5-(4-chlorophenyl)-5H-spiro[diindeno[1,2-b:2′,1′-
e]pyridin-11,3′-indoline]-2′,10,12-trione (4 g).
C33H19N2O4Cl: C (73.00%), H (3.53%), N (5.16%), Found: C (73.04%),
H (3.50%), N (5.12%).
Red powder, M.P. N 300 °C, IR (KBr): 3367, 3055, 2918, 1682,
1599 cm−1, 1H NMR (300 MHz, DMSO d6): δH (ppm) 5.55–5.58 (d,
2H, Ar-H), 6.83–6.86 (d, 1H, Ar-H), 7.22–7.43 (m, 8H, Ar-H), 7.80–
7.93 (m, 2H, Ar-H), 8.04–8.06 (d, 1H, Ar-H), 8.29–8.31 (d, 1H, Ar-
H), 10.82 (s, 1H, NH), 13C NMR (75 MHz, DMSO d6): δC (ppm) 46.2,
111.4, 111.4, 113.9, 121.7, 121.9, 122.1, 127.9, 130.9, 131.2, 131.8,
132.2, 132.6, 133.1, 136.4, 136.8, 137.1, 142.0, 156.5, 177.6, 190.0.
HRMS: calcd for C32H16BrClN2O3: 591.8; found: 592.0 Anal. Calcd
for C32H16BrClN2O3: C (64.94%), H (2.72%), N (4.73%), Found: C
(64.98%), H (2.70%), N (4.76%).
5. 5′-Chloro-5-(4-chlorophenyl)-5H-spiro[diindeno[1,2-b:2′,1′-
e]pyridin-11,3′-indoline]-2′,10,12-trione (4 k).
Red powder, M.P. N 300 °C, IR (KBr): 3379, 3282, 3236, 1691, 1619,
1581 cm−1, 1H NMR (300 MHz, DMSO d6): δH (ppm) 5.55–5.58 (d,
2H, Ar-H), 6.87–6.90 (d, 2H, Ar-H), 7.29–7.61 (m, 8H, Ar-H), 7.85–
7.93 (d, 2H, Ar-H), 8.04–8.06 (d, 1H, Ar-H), 8.28–8.30 (d, 1H, Ar-H),
10.81 (s, 1H, NH), 13C NMR (100 MHz, DMSO d6): δC (ppm) 45.8,
110.4, 110.9, 121.1, 121.4, 121.6, 124.7, 125.7, 128.4, 130.3, 130.4,
130.6, 131.7, 132.1, 132.21, 132.5, 132.6, 136.0, 136.3, 136.6, 141.1,
156.0, 177.3, 189.5 HRMS: calcd for C32H16N2O3Cl2: 547.3; found:
547.1 Anal. Calcd for C32H16N2O3Cl2: C (70.21%), H (2.95%), N
(5.12%), Found: C (70.18%), H (2.90%), N (5.15%).
3. 5′-Chloro-5-phenyl-5H-spiro[diindeno[1,2-b:2′,1′-e]pyridin-11,3′-
indoline]-2′,10,12-trione (4i).
Red powder, M.P. N 300 °C, IR (KBr): 3329, 3052, 1731, 1682,
1580 cm−1, 1H NMR (300 MHz, DMSO d6): δH (ppm) 5.44–5.47 (d,
2H, Ar-H), 6.88–6.90 (m, 1H, Ar-H), 7.10–7.16 (m, 2H, Ar-H), 7.24–
7.29 (m, 4H, Ar-H), 7.42 (s, 1H, Ar-H), 7.59–7.61 (d, 1H, Ar-H),
7.79–7.83 (t, 2H, Ar-H, J = 12 Hz), 7.87–7.96 (d, 3H, Ar-H), 10.81
(s, 1H, NH), 13C NMR (75 MHz, DMSO d6): δC (ppm) 46.4, 110.0,
110.9, 111.2, 120.7, 121.7, 121.9, 122.0, 125.2, 126.1, 126.2, 128.9,
130.2, 130.6, 130.7, 130.9, 131.2, 132.1, 132.1, 132.7, 132.8, 132.9,
133.1, 136.5, 136.6, 138.2, 141.6, 156.6, 177.9, 190.0. HRMS: calcd
for C32H17N2O3Cl: 512.9; found: 512.1 Anal. Calcd for
C32H17N2O3Cl: C (74.93%), H (3.34%), N (5.46%), Found: C (74.90%),
H (3.38%), N (5.42%).
6. 5′-Chloro-5-(4-nitrophenyl)-5H-spiro[diindeno[1,2-b:2′,1′-
e]pyridin-11,3′-indoline]-2′,10,12-trione (4 l).
Red powder, M.P. N 300 °C, IR (KBr): 3276, 3055, 1696, 1580,
1516 cm−1, 1H NMR (300 MHz, DMSO d6): δH (ppm) 5.57–5.59 (d,
2H, Ar-H), 7.10–7.13 (d, 1H, Ar-H), 7.21–7.25 (m, 2H, Ar-H), 7.30–
7.32 (d, 4H, Ar-H), 7.85–7.94 (m, 2H, Ar-H), 8.05–8.07 (d, 1H, Ar-
H), 8.20–8.23 (d, 1H, Ar-H), 8.33–8.36 (d, 1H, Ar-H), 8.48 (s, 1H,
Ar-H), 11.44 (s, 1H, NH), Due to the very low solubility of 4 l, we
were unable to obtain 13C NMR data. HRMS: calcd for
C32H16N3O5Cl: 557.9; found: 558.1 Anal. Calcd for C32H16N3O5Cl: C
(68.89%), H (2.89%), N (7.53%), Found: C (68.85%), H (2.93%), N
(7.50%).
4. 5′-Chloro-5-(4-methoxyphenyl)-5H-spiro[diindeno[1,2-b:2′,1′-
e]pyridin-11,3′-indoline]-2′,10,12-trione (4j).
7. 5-(4-Chlorophenyl)-5′-nitro-5H-spiro[diindeno[1,2-b:2′,1′-
e]pyridin-11,3′-indoline] -2′,10,12-trione (4o).
Red powder, M.P. N 300 °C, IR (KBr): 3347, 3065, 1729, 1707,
1676 cm−1 1H NMR (300 MHz, DMSO d6): δH (ppm) 3.95 (s, 3H,
,
Table 2
OCH3), 5.57–5.60 (d, 2H, Ar-H), 6.89–6.92 (d, 1H, Ar-H), 7.14–
7.31(m, 9H, Ar-H), 7.55–7.56(d, 1H, Ar-H), 7.78–7.81 (d, 1H, Ar-H),
8.06–8.08 (d, 1H, Ar-H), 10.84 (s, 1H, NH), 13C NMR (75 MHz,
DMSO d6): δC (ppm) 18.8, 46.4, 56.2, 109.9, 111.0, 115.6, 115.7,
120.7, 121.8, 122.0, 122.1, 124.6, 125.0, 126.2, 126.3, 128.9, 130.6,
130.9, 131.1, 131.3, 131.6, 132.6, 132.7, 133.0, 136.4, 136.5, 136.6,
141.0, 141.4, 146.3, 148.5, 156.6, 157.2, 161.5, 178.2, 190.2, HRMS:
calcd for C33H19N2O4Cl: 542.9; found: 540.5 Anal. Calcd for
Synthesis of Spiro [diindenopyridine-indoline] trionesa.
Entry
X
Y
Product Time
(min) (%)
Yieldb Atom economyd E-factore
1
2
3
4
5
6
7
8
H
H
4a
20 94
84.4
84.0
81.4
79.7
86.8
85.2
83.4
82.5
84.1
81.8
81.9
80.2
80.6
81.9
80.1
75.8
0.18
0.19
0.23
0.26
0.15
0.17
0.20
0.21
0.19
0.22
0.22
0.24
0.24
0.22
0.24
0.32
H
H
H
OCH3 4b
17
93
Cl
NO2
H
4c
4d
4e
18
25
18
15
17
25
20
15
18
25
25
20
22
35
90c
88
Br
Br
Br
Br
Cl
Cl
Cl
Cl
NO2
92
OCH3 4f
90
Cl
NO2
H
4g
4h
4i
88c
87
Table 1
Screening of the solvents to optimize the reaction conditiona.
9
93c
90c
90c
88c
89
10
11
12
13
14
15
16
OCH3 4j
Entry
Solvent
Time (min)
Yieldb (%)
Cl
NO2
H
4k
4l
4m
1
2
3
4
5
7
8
9
No solvent
Water
Glycerol
Polyethylene glycol
2,2,2-trifluroethanol
Oxalic acid dihydrate: proline
Choline chloride: urea
Choline chloride: oxalic acid
Guanidine hydrochloride: urea
180
150
80
45
60
20
65
35
90
N10
20
50
55
70
94
60
70
60
NO2 OCH3 4n
NO2 Cl
NO2 NO2
90
4o
4p
88c
83
a
Reaction condition: isatin (1 mmol), 1,3-indanedione (2 mmol) and aniline (1 mmol),
LTTM (5 mL)/80 °C.
b
Isolated yields.
Products prepared for first time.
Atom economy = (weight of desired product/sum of molecular weight of all reac-
c
10
d
a
Reaction condition: isatin (1 mmol), 1,3-indanedione (2 mmol) and aniline (1 mmol)
heated at 80 °C in 5 mL of respective solvent.
tant) × 100.
e
E-factor = [mass of waste]/mass of product.
b
Yields refer to pure isolated products.